Curanex Pharmaceuticals Inc (CURX)

Stammdaten

Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients suffering from inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. The company was founded in 1996 and is headquartered in Jericho, New York.

Unternehmen & Branche

NameCuranex Pharmaceuticals Inc
TickerCURX
CIK0002025942
BoerseUS
SektorHealthcare
IndustrieBiotechnology

Wertpapier & Kennzahlen

CUSIP23126K106
ISINUS23126K1060
TypCommon Stock
Marktkapitalisierung11,9 Mio. USD
Beta-8,92
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K-4,225,106-0.1711,580,12411,219,084
2025-09-3010-Q-954,059-0.0414,478,15714,292,202
2025-06-3010-Q-60,3460.00787,174305,431
2025-03-3110-Q-137,583365,777
2024-12-3110-K-361,506-0.03517,935503,360
2024-09-3010-Q-91,166-0.04624,165
2024-06-3010-Q-44,200-0.02715,231
2024-03-3110-Q-80,202129,888

Fondsaktivität (Vorquartalsvergleich)

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
CITADEL ADVISORS LLC104,2780104,27834,474Neu+100,0%
DRW Securities, LLC71,553071,55323,655Neu+100,0%
TWO SIGMA INVESTMENTS, LP61,102061,10220,200Neu+100,0%
RENAISSANCE TECHNOLOGIES LLC59,297059,29719,604Neu+100,0%
XTX Topco Ltd42,385042,38514,012Neu+100,0%
JANE STREET GROUP, LLC24,990024,9908,262Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC18,670018,6706,172Neu+100,0%
UBS Group AG12,991012,9914,300Neu+100,0%
BANK OF AMERICA CORP /DE/3403411Neu+100,0%
HRT FINANCIAL LP12,378012,3784Neu+100,0%

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Fail-to-Deliver (6 Monate)

DatumFTD-MengeKursWert (USD)
2026-03-313.1040,491.521
2026-03-304040,48194
2026-03-2736.0540,5118.388
2026-03-2617.8230,529.268
2026-03-2532.4870,5116.568
2026-03-24100,465
2026-03-2313.0780,466.016
2026-03-207.7960,433.352
2026-03-1926.0880,4511.740
2026-03-1727.5160,4111.282
2026-03-169.4820,383.603
2026-03-139.4840,383.604
2026-03-122090,4390
2026-03-114.2920,411.760
2026-03-1017.5640,386.674
2026-03-09850,3933
2026-03-0611.9340,404.774
2026-03-0412.8590,465.915
2026-03-033.2820,471.543
2026-03-02223.5540,45100.599
2026-02-27473.1840,46217.665
2026-02-26423.1970,32135.423
2026-02-171.7220,29499

Top-Fondshalter

Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.

FondsAnteileWert (USD)Anteil (%)
CITADEL ADVISORS LLC104,27834,47426.38
DRW Securities, LLC71,55323,65518.10
TWO SIGMA INVESTMENTS, LP61,10220,20015.46
RENAISSANCE TECHNOLOGIES LLC59,29719,60415.00
XTX Topco Ltd42,38514,01210.72
JANE STREET GROUP, LLC24,9908,2626.32
GEODE CAPITAL MANAGEMENT, LLC18,6706,1724.72
UBS Group AG12,9914,3003.29
BANK OF AMERICA CORP /DE/34110.01
HRT FINANCIAL LP12,37840.00

Hinweis

Erweitert ×